CONDUCT OF THE RESEARCH PROJECT Sample Clauses

CONDUCT OF THE RESEARCH PROJECT. The parties shall use all reasonable endeavours to carry out the Research Project to a high standard. <Lead institution> shall be responsible for obtaining all necessary ethical, administrative and governmental approvals required to conduct the Research Project as set out in Item 1 of Schedule 2. Austin Health shall supply all personnel, equipment, materials and other things necessary to perform the Research Project as expressed in Item 3 of Schedule 2. Austin Health shall co-operate with Collaborator and shall not interfere with or obstruct the proper performance of the Research Project.
Sample 1Sample 2
AutoNDA by SimpleDocs
CONDUCT OF THE RESEARCH PROJECT. The parties shall use all reasonable endeavours to carry out the Research Project to a high standard. Austin Health shall be responsible for obtaining all necessary ethical, administrative and governmental approvals required to conduct the Research Project as set out in Item 1 of Schedule 2. Austin Health shall supply all personnel, equipment, materials and other things necessary to perform the Research Project as expressed in Item 3 of Schedule 2. Austin Health shall co-operate with Collaborator and shall not interfere with or obstruct the proper performance of the Research Project.
Sample 1Sample 2
CONDUCT OF THE RESEARCH PROJECT. Each of the Research Institution and the Researcher will use, or cause to be used, reasonable scientific efforts to conduct the Research Project in accordance with Appendix B. If at any time the Research Institution or the Researcher makes a good faith determination that (A) the Research Project cannot be conducted substantially in accordance with Appendix B or the Budget (as defined in Section 3(a) of this Agreement) or (B) continued conduct of the Research Project in accordance with Appendix B is unlikely to yield scientifically valid or useful results, the Research Institution shall promptly give notice (a "Change of Circumstances Notice") to the Foundation.
Sample 1
CONDUCT OF THE RESEARCH PROJECT. Collaborator [or the Parties, if both collaborate] shall use all reasonable endeavours to carry out the Research Project to a high standard. Collaborator [or the Parties, if both collaborate shall be responsible for obtaining all necessary ethical, administrative and governmental approvals required to conduct the Research Project as set out in Item 1 of Schedule 2. Collaborator [or the Parties, if both collaborate shall supply all personnel, equipment, materials and other things necessary to perform the Research Project excepting only those items expressed in Item 4 of Schedule 2 to be supplied by Western Health. Western Health shall co-operate with Collaborator and shall not interfere with or obstruct the proper performance of the Research Project.
Sample 1
CONDUCT OF THE RESEARCH PROJECT. The Company hereby agrees to devote such resources and effort as is reasonably necessary to (i) conduct the Research Project in accordance with Appendix A and each Quarterly Research Project Work Plan (as defined in Section 3(c)(i) of this Agreement) and (ii) to complete the Quarterly Research Project Activities described in each Quarterly Research Project Work Plan during the Quarterly Research Project Period for such Quarterly Research Project Work Plan. If at any time the Company makes a good faith determination that (A) the Research Project cannot be conducted substantially in accordance with Appendix A or the Research Project Estimated Schedule and Budget; (B) any Phase of the Research cannot be substantially completed within the time frame set forth in Research Project Estimated Schedule and Budget for such Phase; (C) the Quarterly Research Project Activities described in a Quarterly Research Project Work Plan cannot be substantially completed within the Quarterly Research Project Period for such Quarterly Research Project Work Plan; or (D) the continued conduct of the Research Project in accordance with Appendix A is unlikely to yield scientifically valid or useful results, the Company shall promptly give notice (a “Change of Circumstances Notice”) to the Foundation.
Sample 1
CONDUCT OF THE RESEARCH PROJECT. 3.1 The parties shall use all reasonable endeavours to carry out the Research Project to a high standard.
Sample 1
CONDUCT OF THE RESEARCH PROJECT. The Collaborator [or the Parties, if both collaborate] shall use all reasonable endeavours to carry out the Research Project to a high standard and in accordance with the terms of this Agreement. The Collaborator [or the Parties, if both collaborate] shall be responsible for obtaining all necessary ethical, administrative and governmental approvals required to conduct the Research Project as set out in Item 1 of Schedule 2. The Collaborator shall supply all personnel, equipment, materials and other things necessary to carry out its obligations in the Research Project excepting only those items expressed in Item 4 of Schedule 2 which are to be supplied by Barwon Health.
Sample 1
AutoNDA by SimpleDocs
CONDUCT OF THE RESEARCH PROJECT. Collaborator [or the Parties, if both collaborate] shall use all reasonable endeavours to carry out the Research Project to a high standard. Collaborator [or the Parties, if both collaborate shall be responsible for obtaining all necessary ethical, administrative and governmental approvals required to conduct the Research Project as set out in Item 1 of Schedule 2. Collaborator [or the Parties, if both collaborate shall supply all personnel, equipment, materials and other things necessary to perform the Research Project excepting only those items expressed in Item 4 of Schedule 2 to be supplied by The Institution. The Institution shall co-operate with Collaborator and shall not interfere with or obstruct the proper performance of the Research Project.
Sample 1

Related to CONDUCT OF THE RESEARCH PROJECT

  • Conduct of Research Program Each Party:

  • Development of the Project 4.1 TSP's obligations in development of the Project: Subject to the terms and conditions of this Agreement, the TSP at its own cost and expense shall observe, comply with, perform, undertake and be responsible:

  • Research Program 2.1 University will use reasonable efforts to conduct the Research Program described in Attachment A which is hereby incorporated in full by reference (“Research Program”), and will furnish the facilities necessary to carry out said Research Program. The Research Program will be under the direction of _____________________ (“Principal Investigator”), or his or her successor as mutually agreed to by the Parties and will be con­ducted by the Principal Investigator at the University.

  • Conduct of Research The Parties shall use Diligent Efforts to conduct their respective tasks, as assigned under the Research Plan, throughout the Mode of Action Program and shall conduct the Mode of Action Program in good scientific manner, and in compliance in all material respects with the requirements of applicable laws, rules and regulations and all applicable good laboratory practices to attempt to achieve their objectives efficiently and expeditiously.

  • Development Work The Support Standards do not include development work either (i) on software not licensed from CentralSquare or (ii) development work for enhancements or features that are outside the documented functionality of the Solutions, except such work as may be specifically purchased and outlined in Exhibit 1. CentralSquare retains all Intellectual Property Rights in development work performed and Customer may request consulting and development work from CentralSquare as a separate billable service.

  • Research Matters By entering into this Agreement, the Placement Agent does not provide any promise, either explicitly or implicitly, of favorable or continued research coverage of the Company and the Company hereby acknowledges and agrees that the Placement Agent’s selection as a placement agent for the Offering was in no way conditioned, explicitly or implicitly, on the Placement Agent providing favorable or any research coverage of the Company. In accordance with FINRA Rule 2711(e), the parties acknowledge and agree that the Placement Agent has not directly or indirectly offered favorable research, a specific rating or a specific price target, or threatened to change research, a rating or a price target, to the Company or inducement for the receipt of business or compensation.

  • Conduct of the Business Each of the Company and Parent covenants and agrees that:

  • Research Collaboration Upon FibroGen’s request, the Parties will discuss conducting a research program funded by AstraZeneca and directed toward franchise enhancement and lifecycle management for HIF Compounds or other topics that the Parties determine relevant to the Products and the Field. Upon agreement on the terms of such research program, the Parties will enter into a separate agreement or amend this Agreement accordingly.

  • Research Program Term The Research Program shall be conducted during the period of five years commencing as of the Agreement Date ("Research Program Term"). Upon not later than seventy-five (75) days' prior written notice JT may, in its sole judgment, terminate the Research Program at the end of the third (3/rd/) year and fourth (4/th/) year of the Research Program. The RMC may terminate the Research Program any time during the Research Program Term if it unanimously determines the Research Program is no longer scientifically useful or that all potential Products would not be commercially viable. In case of such an early termination by JT or the RMC, JT shall be exempt from any payment(s) under Section 10(a) that would have become due and payable after the effective date of such early termination. Following any termination of the Research Program (i) that occurs simultaneously with the termination of this Agreement in accordance with Section 13 (i.e., no compound or Lead Compound has been designated previously a Collaboration Lead Compound in accordance with Section 3(b) and no Independent Lead Compound is being developed in accordance with Section 3(m)) or (ii) that is followed at some future date by the termination by JT of Development or co-promotion of any Collaboration Lead Compound and/or Product pursuant to Sections 3(l) or 5(c), respectively, or development of an Independent Lead Compound in accordance with Section 3(m) (A) any licenses granted by Tularik to JT will terminate, (B) JT will grant to Tularik an exclusive, sublicensable, worldwide license, to make, use and sell compounds, Collaboration Lead Compounds or Products under JT's interest in Program Patents and Program Know-How and (C) under the terms and conditions to be separately agreed, JT will also grant to Tularik a nonexclusive, sublicensable, worldwide license under any JT Patent Rights and Know-How to the extent necessary to practice the license granted under the Program Patents and Program Know-How in (B) (including, with respect to compounds, a limited number of JT's library compounds approved by JT); provided, however, that in the event the Research Program terminates but the Agreement has not terminated with respect to designated Collaboration Lead Compounds, Independent Lead Compounds and/or Products as provided in Section 2(g)(ii), Sections 2(g)(A), (B) and (C) shall apply only to those compounds, Collaboration Lead Compounds, Independent Lead Compounds and Products for which Development or co-promotion shall have been terminated and/or to those compounds or Lead Compounds that have not been designated previously a Collaboration Lead Compound in accordance with Section 3(b) or an Independent Lead Compound in accordance with Section 3(m); provided further that in the event that JT elects to pursue a Discontinued Compound or a Non-Proposed Compound on or before the first anniversary of the expiration or termination of the Research Program Term pursuant to Section 3(b)(iii) or 3(b)(iv), respectively, Sections 2(g)(A), (B) and (C) shall not apply to such Discontinued Compound or Non-Proposed Compound until such time as JT shall have terminated the Development or co-promotion of such Discontinued Compound or Non- Proposed Compound. Tularik will then be free to pursue clinical development and registration of such compounds, Lead Compounds and/or Products without obligation to JT except as provided in Section 4(f) or Section 5(c), as appropriate.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

Time is Money Join Law Insider Premium to draft better contracts faster.